Back to results
US 2023/0405058 A1Published application
Extracellular vesicles from prevotella
AssigneeEvelo Biosciences, Inc.
InventorsBrian Goodman, Baundauna Bose, Christopher J.H. Davitt, Sofia M.R. Carlton, William Caffry, Hank Wu
Life of this patent
Estimating the term…
Abstract
Provided herein are methods and compositions related to Prevotella EVs useful as therapeutic agents.
Claims21
1-181. (canceled)
A pharmaceutical composition comprising Prevotella bacterial extracellular vesicles (EVs) isolated from Prevotella Strain B 50329 (NRRL accession number B 50329).
Dependencies are inferred from the claim text.